AlTi Global Inc. Decreases Holdings in CME Group Inc. (NASDAQ:CME)

AlTi Global Inc. lowered its position in CME Group Inc. (NASDAQ:CMEFree Report) by 10.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,637 shares of the financial services provider’s stock after selling 6,532 shares during the quarter. AlTi Global Inc.’s holdings in CME Group were worth $13,043,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of CME. New Age Alpha Advisors LLC grew its holdings in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 43 shares during the last quarter. Avidian Wealth Enterprises LLC grew its holdings in CME Group by 2.6% in the 4th quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider’s stock worth $411,000 after acquiring an additional 45 shares during the last quarter. TFC Financial Management Inc. increased its position in shares of CME Group by 8.4% in the fourth quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider’s stock valued at $137,000 after acquiring an additional 46 shares during the period. Waldron Private Wealth LLC raised its stake in shares of CME Group by 2.0% during the fourth quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider’s stock valued at $549,000 after acquiring an additional 47 shares during the last quarter. Finally, Venturi Wealth Management LLC boosted its holdings in shares of CME Group by 12.1% during the fourth quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider’s stock worth $101,000 after purchasing an additional 47 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Insider Activity at CME Group

In other CME Group news, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total value of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares in the company, valued at $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 30,076 shares of company stock valued at $7,670,976. 0.30% of the stock is owned by corporate insiders.

CME Group Trading Up 1.2 %

NASDAQ CME opened at $280.45 on Friday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $282.10. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock’s fifty day moving average price is $261.34 and its 200-day moving average price is $243.61. The stock has a market cap of $101.06 billion, a P/E ratio of 29.00, a P/E/G ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. CME Group’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm posted $2.50 EPS. As a group, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were issued a $1.25 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a yield of 1.78%. The ex-dividend date was Friday, March 7th. CME Group’s payout ratio is presently 50.30%.

Analyst Ratings Changes

CME has been the topic of a number of research analyst reports. Oppenheimer boosted their price target on CME Group from $269.00 to $279.00 and gave the company an “outperform” rating in a report on Friday, April 11th. Citigroup downgraded CME Group from a “buy” rating to a “neutral” rating and decreased their target price for the company from $255.00 to $250.00 in a report on Monday, January 6th. Bank of America lifted their price target on shares of CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a report on Wednesday, April 2nd. Raymond James upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price objective for the company in a report on Monday, March 10th. Finally, UBS Group lifted their target price on shares of CME Group from $290.00 to $305.00 and gave the company a “buy” rating in a research note on Friday, April 25th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $256.80.

View Our Latest Stock Report on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.